Furthermore, blocking the CCL5/CCR5 axis reduced M2‐type TAM infiltration and LN metastasis in LCN2‐silenced GC cells, suggesting that inhibiting the CCL5/CCR5 axis suppresses LN metastasis in LCN2‐low‐expressing GC. Here, CCR5 is linked to gastric cancer.